Barker, Christopher A <br/><br/>
Adjuvant Pembrolizumab in Resected Stage III Melanoma.  [electronic resource] 

 -  The New England journal of medicine  08 2018 
 - 593 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>1533-4406 
<br/><br/><label>Standard No.: </label>10.1056/NEJMc1807505  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal, Humanized<br/>Humans<br/>Melanoma<br/>Skin Neoplasms